Cargando…

Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)

PURPOSE: The MERCURY study aimed to evaluate the effects on visual acuity and psychological symptoms, and safety, of ranibizumab and subsequent treatment in patients with diabetic macular oedema (DME) and impaired visual acuity (VA). We report data from the prespecified 12-month interim analysis. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakamoto, Taiji, Shimura, Masahiko, Kitano, Shigehiko, Ohji, Masahito, Ogura, Yuichiro, Yamashita, Hidetoshi, Suzaki, Makoto, Mori, Kimie, Ohashi, Yohei, Yap, Poh Sin, Kaneko, Takeumi, Ishibashi, Tatsuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Retinal Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786783/ https://www.ncbi.nlm.nih.gov/pubmed/34477927 http://dx.doi.org/10.1007/s00417-021-05308-8

Ejemplares similares

Two-year visual and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)
por: Sakamoto, Taiji, et al.
Publicado: (2022)

Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
por: Wong, Yun, et al.
Publicado: (2016)

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)

Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study
por: Ohji, Masahito, et al.
Publicado: (2021)

One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy
por: Yamakiri, Keita, et al.
Publicado: (2008)

An AI model to estimate visual acuity based solely on cross-sectional OCT imaging of various diseases
por: Inoda, Satoru, et al.
Publicado: (2023)

Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye
por: Sugimoto, Masahiko, et al.
Publicado: (2017)

Disease-modifying effects of ranibizumab for central retinal vein occlusion
por: Huang, Jason M., et al.
Publicado: (2021)

Long-term intraocular pressure changes after vitrectomy for epiretinal membrane and macular hole
por: Fujikawa, Masato, et al.
Publicado: (2013)

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy
por: Mikhail, Michael, et al.
Publicado: (2018)

Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
por: Marquis, Liza-Marie, et al.
Publicado: (2020)

Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
por: Zirpel, Johanna J., et al.
Publicado: (2021)

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
por: Karst, Sonja G., et al.
Publicado: (2017)

Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
por: Liu, Siyin, et al.
Publicado: (2022)

Delayed follow-up of medical retina patients due to COVID-19: impact on disease activity and visual acuity
por: Stone, Lydia G., et al.
Publicado: (2021)

Evaluating an automated machine learning model that predicts visual acuity outcomes in patients with neovascular age-related macular degeneration
por: Abbas, Abdallah, et al.
Publicado: (2022)

Postponed care due to COVID-19 lockdown impact on visual acuity of retinal vein occlusion patients: a large cohort
por: Cohen, Ram, et al.
Publicado: (2022)

Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials
por: Takahashi, Kanji, et al.
Publicado: (2023)

Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting
por: Granstam, Elisabet, et al.
Publicado: (2021)

Correlation between change in central subfield thickness and change in visual acuity in macular edema due to retinal vein occlusion: post hoc analysis of COPERNICUS, GALILEO, and VIBRANT
por: Gu, Sophie Z., et al.
Publicado: (2022)

Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial
por: Hoerauf, Hans, et al.
Publicado: (2011)

Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion
por: Fortunato, Pina, et al.
Publicado: (2009)

The effect of a preoperative subconjuntival injection of dexamethasone on blood–retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial
por: Bali, Ernesto, et al.
Publicado: (2010)

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
por: Hörster, Robert, et al.
Publicado: (2010)

Pattern recognition can detect subtle field defects in eyes of HIV individuals without retinitis under HAART
por: Goldbaum, Michael H., et al.
Publicado: (2010)

Near-infrared reflectance imaging of neovascular age-related macular degeneration
por: Theelen, Thomas, et al.
Publicado: (2009)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

Pars plana vitrectomy for the repair of primary, inferior rhegmatogenous retinal detachment associated to inferior breaks. A comparison of a 25-gauge versus a 20-gauge system
por: dell’Omo, Roberto, et al.
Publicado: (2012)

Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
por: Fassnacht-Riederle, Heidi, et al.
Publicado: (2014)

Posterior vitreous detachment following intravitreal drug injection
por: Geck, Ulrich, et al.
Publicado: (2013)

The price for reduced light toxicity: Do endoilluminator spectral filters decrease color contrast during Brilliant Blue G–assisted chromovitrectomy?
por: Henrich, Paul B., et al.
Publicado: (2013)

Can optical coherence tomography replace fluorescein angiography in detection of ischemic diabetic maculopathy?
por: Dmuchowska, Diana Anna, et al.
Publicado: (2013)

Effect of sulodexide in patients with non-proliferative diabetic retinopathy: diabetic retinopathy sulodexide study (DRESS)
por: Song, Ji Hun, et al.
Publicado: (2014)

A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit)
por: Stalmans, Peter
Publicado: (2016)

Photopic full-field electroretinography and optical coherence tomography in type 1 diabetic retinopathy
por: Jansson, Ragnhild Wivestad, et al.
Publicado: (2015)

Detecting signs of retinal leakage in exudative AMD using Cirrus OCT versus SL SCAN-1, a novel integrated FD-OCT into a common slit lamp
por: Stehouwer, M., et al.
Publicado: (2015)

Rhegmatogenous retinal detachment following intravitreal ocriplasmin
por: Madi, Haifa A., et al.
Publicado: (2016)

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
por: Korobelnik, Jean-François, et al.
Publicado: (2016)

Investigation of precursor lesions of polypoidal choroidal vasculopathy using contralateral eye findings
por: Kang, Se Woong, et al.
Publicado: (2016)

Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial
por: Eter, Nicole, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n449ihlegltjpninrr68u4duam